Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Covid-19: Moderna applies for US and EU approval as vaccine trial reports 94.1% efficacy.

Literature DB >> 33268462

Covid-19: Moderna applies for US and EU approval as vaccine trial reports 94.1% efficacy.

Elisabeth Mahase¹.
1. The BMJ.

Abstract

Entities: Disease

Year: 2020 PMID： 33268462 DOI： 10.1136/bmj.m4709

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

Keyword Cloud
Cited

× No keyword cloud information.

23 in total

1. Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance.

Authors: Andrey S Shkoda; Vladimir A Gushchin; Darya A Ogarkova; Svetlana V Stavitskaya; Olga E Orlova; Nadezhda A Kuznetsova; Elena N Keruntu; Andrei A Pochtovyi; Alexander V Pukhov; Denis A Kleymenov; Vasyli G Krzhanovsky; Daria V Vasina; Nataliya V Shkuratova; Elena V Shidlovskaya; Alexey L Gorbunov; Daria D Kustova; Evgeniya A Mazurina; Sofya R Kozlova; Alexandra V Soboleva; Igor V Grigoriev; Lyudmila L Pankratyeva; Alina S Odintsova; Elizaveta D Belyaeva; Arina A Bessonova; Lyudmila A Vasilchenko; Igor P Lupu; Ruslan R Adgamov; Artem P Tkachuk; Elizaveta A Tokarskaya; Denis Y Logunov; Alexander L Gintsburg
Journal: Vaccines (Basel) Date: 2022-06-13

2. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.

Authors: Sankar Prasad Chaki; Melissa M Kahl-McDonagh; Benjamin W Neuman; Kurt A Zuelke
Journal: Microbiol Spectr Date: 2022-05-31

3. In silico Exploration of Interactions Between Potential COVID-19 Antiviral Treatments and the Pore of the hERG Potassium Channel-A Drug Antitarget.

Authors: Ehab Al-Moubarak; Mohsen Sharifi; Jules C Hancox
Journal: Front Cardiovasc Med Date: 2021-05-04

Covid-19: Moderna applies for US and EU approval as vaccine trial reports 94.1% efficacy.

1. Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance.

2. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.

3. In silico Exploration of Interactions Between Potential COVID-19 Antiviral Treatments and the Pore of the hERG Potassium Channel-A Drug Antitarget.

4. Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain.

5. Immunogenicity of Multiple Doses of pDNA Vaccines against SARS-CoV-2.

6. In silico studies on stilbenolignan analogues as SARS-CoV-2 Mpro inhibitors.

Review 7. Immunity to SARS-CoV-2: Lessons Learned.

8. What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments.

Review 9. Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies.

10. Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain.